These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30706227)

  • 1. Comprehensive Genetic Search to Clarify the Molecular Mechanism of Drug Resistance Identifies ASCL2-LEF1/TSPAN8 Axis in Colorectal Cancer.
    Tanaka T; Kojima K; Yokota K; Tanaka Y; Ooizumi Y; Ishii S; Nishizawa N; Yokoi K; Ushiku H; Kikuchi M; Kojo K; Minatani N; Katoh H; Sato T; Nakamura T; Sawanobori M; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 May; 26(5):1401-1411. PubMed ID: 30706227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
    Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
    J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
    Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
    PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan.
    Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L
    Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer.
    Kikuchi M; Yamashita K; Waraya M; Minatani N; Ushiku H; Kojo K; Ema A; Kosaka Y; Katoh H; Sengoku N; Enomoto T; Tanino H; Sawanobori M; Watanabe M
    Oncotarget; 2016 Jan; 7(2):1741-53. PubMed ID: 26646320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression.
    Basu S; Gavert N; Brabletz T; Ben-Ze'ev A
    Cancer Lett; 2018 Jun; 424():9-18. PubMed ID: 29551399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
    Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
    Stange DE; Engel F; Longerich T; Koo BK; Koch M; Delhomme N; Aigner M; Toedt G; Schirmacher P; Lichter P; Weitz J; Radlwimmer B
    Gut; 2010 Sep; 59(9):1236-44. PubMed ID: 20479215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
    Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
    Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TET2-BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter.
    Shang Y; Jiang T; Ran L; Hu W; Wu Y; Ye J; Peng Z; Chen L; Wang R
    J Biol Chem; 2022 Jul; 298(7):102095. PubMed ID: 35660018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSPAN8 promotes colorectal cancer cell growth and migration in LSD1-dependent manner.
    Zhang HS; Liu HY; Zhou Z; Sun HL; Liu MY
    Life Sci; 2020 Jan; 241():117114. PubMed ID: 31790687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray Analysis of Long Non-coding RNA Expression Profile Associated with 5-Fluorouracil-Based Chemoradiation Resistance in Colorectal Cancer Cells.
    Xiong W; Jiang YX; Ai YQ; Liu S; Wu XR; Cui JG; Qin JY; Liu Y; Xia YX; Ju YH; He WJ; Wang Y; Li YF; Hou Y; Wang L; Li WH
    Asian Pac J Cancer Prev; 2015; 16(8):3395-402. PubMed ID: 25921151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achaete scute-like 2 suppresses CDX2 expression and inhibits intestinal neoplastic epithelial cell differentiation.
    Shang Y; Pan Q; Chen L; Ye J; Zhong X; Li X; Meng L; Guo J; Tian Y; He Y; Chen W; Peng Z; Wang R
    Oncotarget; 2015 Oct; 6(31):30993-1006. PubMed ID: 26307678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Mechanism of Immune Evasion Associated with the Master Regulator ASCL2 in Microsatellite Stability in Colorectal Cancer.
    Yang Q; Huang G; Li L; Li E; Xu L
    J Immunol Res; 2021; 2021():5964752. PubMed ID: 33628843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achaete-scute like 2 (ascl2) is a target of Wnt signalling and is upregulated in intestinal neoplasia.
    Jubb AM; Chalasani S; Frantz GD; Smits R; Grabsch HI; Kavi V; Maughan NJ; Hillan KJ; Quirke P; Koeppen H
    Oncogene; 2006 Jun; 25(24):3445-57. PubMed ID: 16568095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
    Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
    Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of TSPAN8 in consensus molecular subtype 3 colorectal cancer.
    Suwatthanarak T; Tanjak P; Chaiboonchoe A; Acharayothin O; Thanormjit K; Chanthercrob J; Suwatthanarak T; Niyomchan A; Tanaka M; Okochi M; Pongpaibul A; Chalermwai WV; Trakarnsanga A; Methasate A; Pithukpakorn M; Chinswangwatanakul V
    Exp Mol Pathol; 2024 Jun; 137():104911. PubMed ID: 38861838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo.
    Wang WJ; Yao Y; Jiang LL; Hu TH; Ma JQ; Liao ZJ; Yao JT; Li DF; Wang SH; Nan KJ
    PLoS One; 2013; 8(10):e76596. PubMed ID: 24098538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.
    Petty RD; Samuel LM; Murray GI; MacDonald G; O'Kelly T; Loudon M; Binnie N; Aly E; McKinlay A; Wang W; Gilbert F; Semple S; Collie-Duguid ES
    BMC Cancer; 2009 Dec; 9():434. PubMed ID: 20003335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.